Breast Cancer Chemotherapy along with the Endocrine System
Friday, May 13th, 2011cancer chemotherapy affects the function of the ovaries in pre-menopause, specifically its ability to produce estrogen and progesterone. The ovaries secrete these hormones from a cyclic manner in reply to trigger hormones caused by the anterior pituitary gland. During the later a portion of a ladies reproductive life, during her late 40s or early 50s, the ovaries not any longer produce these hormones and she is thus entering menopause. This technique, where the ovaries de-activate their sex hormone production, takes several months into a year or so to happen. The gradual reduction in estrogen and progesterone is commonly amid menopausal symptoms along the lines of cessation of menstrual periods, hot flashes and vaginal dryness. Undergoing chemotherapy may accelerate menopause.
This basically indicates that in conjunction with the same time girls is coping with cancers of the breast diagnosis, she must handle the changes and possible undesirable results of the change of life. The same holds true for woman on hormone replacement therapy who must abruptly stop her hormone treatment due to proper diagnosis of cancer of the breast.
The association between breast cancer and endocrine status is complex and varies with each lady. The original therapy to get a recently diagnosed cancer of the breast patient is usually to stop hormone replacement therapy. Simply because it’s been found from numerous researches that estrogen increases the risk or breast cancer. During the past, women with cancer of the breast were advised not to ever resume hormone replacement therapy or begin it. Fortunately, this practice has changed and nowadays, treatment is determined by each woman’s individual situation. Nevertheless, it’s essential to obtain the risks and benefits of hormone replacement therapy on your disease.